Mexico’s General Prosecution (PGR) was presented last week with a historic charge by the Federal Commission for Economic Competition (COFECE) – the first instance of criminal charges filed over monopolistic practices, which affected he purchase of various public sector institutions.
The charges state that the illegal sale procedure implied “serious damage to the Healthcare sector, as the resources acquired directly affect the services provided by the State to the general population.”
The agency added that they have collected evidence of collusion between several bidders for public contracts in the health sector allocated between 2009 and 2015, affecting the acquisition of resources for various public health institutions worth over $1.2 billion pesos.
Full Content: Proceso
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Pennsylvania Governor Opposes Nippon Steel’s Bid for U.S. Steel, Citing Union Concerns
Jul 30, 2024 by
CPI
Live Nation Attorneys Granted Limited Access to Confidential Documents in Antitrust Case
Jul 30, 2024 by
CPI
UK’s CMA Deepens Investigation into Amex GBT’s Acquisition of CWT
Jul 30, 2024 by
CPI
EU Regulators Advocate Formalizing Disinformation Code Under DSA
Jul 30, 2024 by
CPI
Spain’s Antitrust Watchdog Slaps Booking.com with €413.2 Million Fine for Market Abuses
Jul 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Trade & Antitrust
Jul 26, 2024 by
CPI
What is Wrong with the WTO Discipline on Subsidies?
Jul 26, 2024 by
CPI
The Abiding Tension Between Trade Remedy Law and Antitrust
Jul 26, 2024 by
CPI
Trade and Antitrust: An End to Isolationism
Jul 26, 2024 by
CPI
International Trade Law and Domestic Regulation of Generative Artificial Intelligence: Divergent Approaches?
Jul 26, 2024 by
CPI